Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for post-root canal pain in irreversible pulpitis
IRCT20240109060657N1Phase 3Completed
- Sponsor
- Bushehr University of Medical Sciences
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexamethasone in irreversible pulpitis (3 arms), sponsored by Bushehr University of Medical Sciences. Primary endpoint: Average pain intensity. Started Feb 2024; status: completed.
02
Drugs
dexamethasone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20240109060657N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240109060657N1.